Sandu Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹19 crore and net profit of ₹0.79 crore for the September 2026 quarter.
Sandu Pharma. (BSE: SANDUPHQ) closed at ₹35.71 on 20 Nov 2026, down 14.9% over the past year. Its market capitalisation is ₹34 crore and it trades at 16.9 times earnings.
Incorporated in 1985, Sandu Pharmaceuticals Ltd is a manufacturer of Ayurvedic Medicines.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.